VLDLR and hyperplasia: In addition, binding to low-density lipoprotein receptor-related protein 1 (LRP1), apolipoprotein E receptor-2 (ApoER2), very-low-density lipoprotein receptor (VLDLR), and other receptors promotes vascular endothelial hyperplasia and increases lipoprotein levels [12].